Hemostemix (HEM) News Today C$0.08 0.00 (0.00%) As of 05/28/2025 03:52 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesInsider TradesBuy This Stock HEM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Hemostemix Presents at TERMIS 2025, Freiburg, GermanyMay 20, 2025 | theglobeandmail.comHemostemix Inc.May 12, 2025 | barrons.comHemostemix Closes Private Placement of USD $336,500 at $0.295 per ShareMay 12, 2025 | finance.yahoo.comHemostemix Secures $336,500 in Private Placement to Bolster GrowthMay 12, 2025 | tipranks.comHemostemix at Invest StuttgartMay 8, 2025 | finance.yahoo.comHemostemix Inc. (HEM.V)April 22, 2025 | finance.yahoo.comHemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical TrialMarch 17, 2025 | theglobeandmail.comInsider Buying: Hemostemix Inc. (CVE:HEM) Director Purchases 200,000 Shares of StockMarch 11, 2025 | insidertrades.comHemostemix Sells Its 23rd ACP-01 Therapy Convertible DebentureMarch 5, 2025 | finance.yahoo.comInsider Selling: Hemostemix Inc. (CVE:HEM) Director Sells 96,464 Shares of StockMarch 1, 2025 | insidertrades.comHemostemix Licenses CytoImmune's BioReactor TechnologiesFebruary 20, 2025 | finance.yahoo.comRETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor TechnologiesFebruary 20, 2025 | theglobeandmail.comHemostemix Inc. (HMTXF)February 16, 2025 | finance.yahoo.comHemostemix Provides Corporate UpdateFebruary 13, 2025 | finance.yahoo.comHemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma CertificationFebruary 11, 2025 | finance.yahoo.comHemostemix Announces First Sales Orders for ACP-01January 30, 2025 | finance.yahoo.comHemostemix Up-lists to TradeGateExchange in GermanyJanuary 27, 2025 | finance.yahoo.comHemostemix Up-Lists to OTCQB While it Presents its Global Scale-Up Strategy at Two Investor Conferences in Puerto RicoJanuary 23, 2025 | finance.yahoo.comHemostemix Announces Grant of Stock OptionsJanuary 22, 2025 | finance.yahoo.comHemostemix Presents at Puerto Rico Investor Summits: Showcasing Global Scale-Up Strategy and Economic ImpactJanuary 20, 2025 | finance.yahoo.comHemostemix Settlement via Depository Trust Company Plus OTCQB UpdateJanuary 14, 2025 | finance.yahoo.comHemostemix stock takes off after amended manufacturing dealJanuary 9, 2025 | msn.comHemostemix Inc.: Hemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-UpJanuary 9, 2025 | finanznachrichten.deHemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-UpJanuary 9, 2025 | finance.yahoo.comHemostemix Announces the Incorporation of Hemostemix PR Inc: 50% Reimbursement of R&D Expenses in CashJanuary 6, 2025 | stockhouse.comHemostemix is Up-Listing in the USA to Generate LiquidityJanuary 3, 2025 | finance.yahoo.comHemostemix's Social Media Awareness of "Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining TractionJanuary 2, 2025 | finance.yahoo.comHemostemix Announces $2,725,982 Update to Second ClosingDecember 4, 2024 | theglobeandmail.comHemostemix Announces ACP-01 Treatment-Purchase Available with Social Media Campaign UnderwayNovember 26, 2024 | finance.yahoo.comHemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private PlacementOctober 31, 2024 | finance.yahoo.comTUGAF TUGA Innovations, Inc.October 26, 2024 | seekingalpha.comHemostemix's Private PlacementOctober 11, 2024 | finance.yahoo.comHemostemix Inc. (CVE:HEM) Director Sells C$21,612.50 in StockOctober 9, 2024 | insidertrades.comCanadian Investment Regulatory Organization Trade Resumption - HEMAugust 2, 2024 | ca.finance.yahoo.comHemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01August 2, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - HEMAugust 1, 2024 | finance.yahoo.comClosing Bell: Hemostemix Inc flat on Monday (HEM)July 24, 2024 | theglobeandmail.comGlobal Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsightMay 2, 2024 | finance.yahoo.comHemostemix Inc.: Hemostemix Announces Engagement of Oak Hill Asset Management Inc.March 7, 2024 | finanznachrichten.deHemostemix Announces Engagement of Oak Hill Asset Management Inc.March 7, 2024 | finance.yahoo.comHemostemix: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (HEM)February 20, 2024 | theglobeandmail.comHemostemix: Top 10 Undervalued Biotechnology Industry Stocks (HEM)February 19, 2024 | theglobeandmail.comHemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental SciencesFebruary 6, 2024 | finance.yahoo.comHemostemix Inc HMTXFJanuary 19, 2024 | morningstar.comHemostemix Inc.: Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart DiseaseOctober 30, 2023 | finanznachrichten.deHemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart DiseaseOctober 30, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc down on Thursday (HEM)October 20, 2023 | theglobeandmail.comHemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant ApplicationsAugust 29, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc up on Friday (HEM)August 8, 2023 | theglobeandmail.comHemostemix Inc.: Hemostemix Closes $403,539 of the Unit Private PlacementJune 28, 2023 | finanznachrichten.de Get Hemostemix News Delivered to You Automatically Sign up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter. Email Address HEM Media Mentions By Week HEM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HEM News Sentiment▼0.000.87▲Average Medical News Sentiment HEM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HEM Articles This Week▼00▲HEM Articles Average Week Get Hemostemix News Delivered to You Automatically Sign up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Helix BioPharma News Microbix Biosystems News Oncolytics Biotech News Devonian Health Group News Sirona Biochem News Kane Biotech News Innovotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:HEM) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemostemix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HEM Stock Free HEM Stock Alerts